Evogene (EVGN) is scheduled to report Q2 earnings on August 18, 2026. Analysts estimate EPS of $-0.27 and quarterly revenue of $325.00K.
In the most recent quarter (Q1), Evogene reported EPS of $-0.60, missing estimates of $-0.27 by 1.22%. Revenue came in at $334.00K, missing the estimate of $350.00K by 0.05%.
Evogene has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Evogene has averaged an EPS surprise of 0.75% and a revenue surprise of 0.19%.
Analyze the earnings history of Evogene using advanced sorting and filters.
The chart below shows Evogene's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Evogene's reported revenue compared to analyst estimates over recent quarters.
Evogene (EVGN) is scheduled to report earnings on August 18, 2026. The last reported earnings were for reported on May 20, 2026 for Q1.
The Actual EPS was $-0.60, which missed the estimate of $-0.27.
The Actual Revenue was $334.00K, which missed the estimate of $350.00K.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-20 | $-0.60 | $-0.27 | -122.2 % |
| Q4 | 2026-03-05 | $-0.61 | $-0.26 | -134.6 % |
| Q3 | 2025-11-20 | $-0.31 | $-0.41 | 24.4 % |
| Q2 | 2025-08-19 | $-0.50 | $-0.63 | 20.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-20 | $334.00K | $350.00K | -4.57 % |
| Q4 | 2026-03-05 | $314.00K | $275.00K | 14.2 % |
| Q3 | 2025-11-20 | $312.00K | $650.00K | -52.0 % |
| Q2 | 2025-08-19 | $884.00K | $930.00K | -4.95 % |